The top 10 projected best-selling medications in 2026, including GLP-1 drugs and AbbVie's Skyrizi, have expected global sales reaching up to $31 billiion.

Roller-coaster healthcare stock Hims & Hers Health ( HIMS -1.34%), whose stock got devastated last week by worries that it ...

A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly ...

Ozempic and other similar drugs must be injected. Messer describes the needle as “small, the size of two human hairs.” ...

The company’s revenue in Q4 2024 witnessed an increase of 45% to $13.53 billion due to the volume growth from Mounjaro and Zepbound. Non-incretin revenue increased 20% as compared to Q4 2023.

CEO David Ricks got a 10% raise in 2024, as a surge in demand for weigh-loss drugs has propelled the pharma giant into the ...

Presiding over the upward trajectory of Eli Lilly over the last eight years is paying off nicely for CEO David Ricks. | ...

Megan Stalter knows how to spot a dirty little secret. The 34-year-old actress – known for playing Kayla in the Max drama “Hacks” – claimed that people who lie about using Ozempic are not very good at ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...